Vilawan Luankongsomchit is a Researcher at the Health Intervention and Technology Assessment Program Foundation (HITAP). She holds a Bachelor of Science in Veterinary Technology from Kasetsart University and a Master of Science through a joint program between Kasetsart University and the University of Toulouse, France, specializing in One Health an

Pritaporn Kingkaew has been a researcher at HITAP since 2007. She graduated from a joint programme between Srinakharinwirot University, Thailand and the University of Nottingham, UK in 2007 with a Bachelor’s degree in Pharmacy. In 2009, she was awarded the HITAP scholarship to pursue a Master’s degree in Health Economics from the University of York

Yot Teerawattananon is a Assistant Secretary General of the Foundation & Senior Researcher of the Health Intervention and Technology Assessment Program (HITAP), which is a semi-autonomous research institute of Thailand’s Ministry of Public Health. The works of HITAP have been used to inform policy decisions regarding the adoption of medicines,

Dr. Wanrudee Isaranuwatchai is a Secretary General and Senior Researcher of the Health Intervention and Technology Assessment Program Foundation (HITAP), Thailand. She is also an Affiliated Scientist at St. Michael’s Hospital, and an Associate Professor at the Institute of Health Policy, Management and Evaluation, University of Toronto, in Canada.H

Management of advanced prostate cancer, particularly in cases of metastatic castration-resistant prostate cancer (mCRPC), typically involves first-line treatment with the chemotherapeutic agent docetaxel. Nevertheless, disease progression following docetaxel therapy remains a major challenge, as there are currently no therapeutic options listed in

Abstract During COVID-19 pandemic, telemedicine was a strategy to facilitate healthcare service delivery minimizing the risk of direct exposure among people. In Thailand, the National Health Security Office has included telemedicine services under the Universal Coverage Scheme to support social d

Economic evaluation of HLA-B*1502 screening for preventing carbamazepine- induced Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) is prioritized by stakeholders under ‘Research for development of health benefit package under universal coverage scheme’. The study carried out an evidence to inform the Subcommittee for Developm

กระทรวงสาธารณสุขของประเทศไทยและองค์การอนามัยโลก ได้จัดทำยุทธศาสตร์ความร่วมมือระหว่างรัฐบาลไทยและองค์การอนามัยโลก (WHO Country Co

ความก้าวหน้าทางด้านวิทยาศาสตร์ขั้นสูงที่เกี่ยวข้องกับยีนส์ เซลล์และเนื้อเยื่อ ทำให้เกิดนวัตกรรมสำหรับการรักษาโรคที่ไม่

This project aims to study the health screening system in developed countries and in Thailand in terms of structure, authority and management of the organizations. In addition the market value of health screening services in both public and private sectors in Thailand will be estimated.  201-347-2553health screening,health screening systems,popul